Table 1.

Baseline Demographic Prescription Drug Misuse (PDM) screening results and clinical characteristics for participants enrolled in ED-LINC (n=30)

Variable	n (%)
Demographics
Age m(SD)	44.6 (13.5)
Female	10 (33)
Currently homeless or temporarily housed	8 (27)
Race
White	18(60)
African-American	6(20)
American Indian/Alaskan Native	3(10)
Other	3(10)
PDM Screening Results
Risk for prescription stimulant misuse	11 (37)
Risk for prescription sedative misuse	6 (20)
Risk for prescription opioid misuse	29 (97)
Clinical Characteristics at Baseline
Opioid for pain management listed as home medication	15 (50)
Sedative listed as home medication	4 (14)
Stimulant listed as home medication	0 (0)
Receiving Medication Assisted Treatment (MAT) for opioid use disorder	7 (23)
Methadone	6 (86)
Buprenorphine	1 (14)
Admitted to the hospital	11 (37)
Admitted to the ICU	3 (27)
Received surgery	4 (36)
Received social work services	7 (64)
Received SBIRT as inpatient	1 (9)
Seen by Anesthesia Pain Service	2 (18)
Injury related to assault/violence	3 (10)
Received prescription for opioids at discharge	14 (47)
Received prescription for sedatives at discharge	2 (7)
Received prescription for stimulants at discharge	0 (0)
Received social work services in the ED	7 (23)
Received chemical dependency services from ED	1 (10)
Seen by Psychiatry	0 (0)